Here, we presented a case of HLH following treatment with an anti-PD-1 antibody of tislelizumab in a patient with MSI-H colon cancer and co-existing systemic lupus erythematosus (SLE). This evidence concerns the gene PDCD1 and hemophagocytic syndrome.